United Therapeutics Corporation UTHR shares plunged around 9% on Monday after the company announced that regulatory issues will delay the planned U.S. launch of RemoSynch - an implantable pump for ...
United Therapeutics Corporation’s UTHR revealed though an 8-K filing that it was informed (Mar 15, 2016) by its partner Medtronic plc MDT that the FDA had issued a response letter to Medtronic’s ...
In finding that Sandoz and RareGen failed to demonstrate they were likely to prevail in the litigation, the Court noted that Sandoz and RareGen "produced no evidence UTC's purchase of [the cartridges ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results